Synthesis of chiral pharmaceutical intermediates by biocatalysis
暂无分享,去创建一个
[1] U. Bornscheuer,et al. Directed evolution of lipases and esterases. , 2004, Methods in enzymology.
[2] V. Urlacher,et al. Recent advances in oxygenase-catalyzed biotransformations. , 2006, Current opinion in chemical biology.
[3] C. Augé,et al. Synthesis with immobilized enzyme of the most important sialic acid. , 1984 .
[4] Alexander Varvak,et al. Development of an efficient, scalable, aldolase-catalyzed process for enantioselective synthesis of statin intermediates. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[5] D. Ghisotti,et al. RECOMBINANT BACTERIAL CELLS AS EFFICIENT BIOCATALYSTS FOR THE PRODUCTION OF NUCLEOSIDES , 2001, Nucleosides, nucleotides & nucleic acids.
[6] Ramesh N. Patel,et al. Microbial synthesis of (2R,3S)-(-)-N-benzoyl-3-phenyl isoserine ethyl ester-a taxol side-chain synthon , 1993 .
[7] Radka Snajdrova,et al. Resolution of fused bicyclic ketones by a recombinant biocatalyst expressing the Baeyer-Villiger monooxygenase gene Rv3049c from Mycobacterium tuberculosis H37Rv. , 2006, Bioorganic & medicinal chemistry letters.
[8] E. Gelmann,et al. The Acquired Immunodeficiency Syndrome: An Update , 1985 .
[9] Ramesh N. Patel,et al. Enantioselective microbial reduction of 2-oxo-2-(1′,2′,3′,4′-tetrahydro-1′,1′,4′,4′-tetramethyl-6′-naphthalenyl)acetic acid and its ethyl ester , 2002 .
[10] Ramesh N. Patel,et al. Stereoselective enzymatic hydrolysis of 2-cyclohexyl-and 2-phenyl-1,3-propanediol diacetate in biphasic systems , 1990, Applied Microbiology and Biotechnology.
[11] Ramesh N. Patel,et al. Deracemization of racemic 1,2-diol by biocatalytic stereoinversion , 1999 .
[12] C. Cass,et al. The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs , 2007, Cancer and Metastasis Reviews.
[13] Ramesh N. Patel,et al. Synthesis of ethyl and t-butyl (3R,5S)-dihydroxy-6-benzyloxy hexanoates via diastereo- and enantioselective microbial reduction , 2006 .
[14] M. Dawson,et al. An efficient process for production of N-acetylneuraminic acid using N-acetylneuraminic acid aldolase. , 1997, Enzyme and microbial technology.
[15] R. Müller,et al. Myxobacteria: proficient producers of novel natural products with various biological activities--past and future biotechnological aspects with the focus on the genus Sorangium. , 2003, Journal of biotechnology.
[16] S. Simon,et al. Neuropeptides and capsaicin stimulate the release of inflammatory cytokines in a human bronchial epithelial cell line , 1999, Neuropeptides.
[17] Ramesh N. Patel,et al. Stereoselective microbial/enzymatic oxidation of (exo, exo)-7-oxabicyclo [2.2.1] heptane-2,3-dimethanol to the corresponding chiral lactol and lactone , 1992 .
[18] R. Madsen,et al. Enyne Metathesis Catalyzed by Ruthenium Carbene Complexes , 2003 .
[19] H. Schwab,et al. The synthesis of chiral cyanohydrins by oxynitrilases. , 2000, Trends in biotechnology.
[20] K. Nicolaou,et al. Chemical Biology of Epothilones. , 1998, Angewandte Chemie.
[21] H. Bonkovsky,et al. Comparative Effects of Different Doses of Ribavirin Plus Interferon-α2b for Therapy of Chronic Hepatitis C: Results of a Controlled, Randomized Trial , 2001, Digestive Diseases and Sciences.
[22] N. Thornberry,et al. Discovery of JANUVIA TM (Sitagliptin), a Selective Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type2 Diabetes. , 2007 .
[23] W. Kroutil,et al. Deracemization of compounds possessing a sec-alcohol or -amino group through a cyclic oxidation–reduction sequence: a kinetic treatment , 1998 .
[24] J. McHutchison,et al. Treatment of hepatitis C with interferon and ribavirin , 2000, Journal of gastroenterology and hepatology.
[25] M. Fraaije,et al. Enzymatic kinetic resolution of racemic ketones catalyzed by Baeyer-Villiger monooxygenases , 2007 .
[26] M. Page,et al. Chemoenzymatic dynamic kinetic resolution of secondary amines , 2007 .
[27] J. Tao,et al. An efficient enzymatic preparation of rhinovirus protease inhibitor intermediates , 2004 .
[28] Sushil K. Srivastava,et al. Process Research and Development for an Efficient Synthesis of the HIV Protease Inhibitor BMS-232632 , 2002 .
[29] J. B. Jones,et al. Enzymes in organic synthesis. 32. Stereospecific horse liver alcohol dehydrogenase-catalyzed oxidations of exo- and endo-oxabicyclic meso diols , 1984 .
[30] A. Greene,et al. An efficient, enantioselective synthesis of the taxol side chain , 1986 .
[31] Sakayu Shimizu,et al. Whole organism biocatalysis. , 2005, Current opinion in chemical biology.
[32] M. Mihovilovic,et al. Microbial Baeyer-Villiger oxidation of terpenones by recombinant whole-cell biocatalysts--formation of enantiocomplementary regioisomeric lactones. , 2007, Organic & biomolecular chemistry.
[33] Michael Müller,et al. Thiamin-diphosphate-dependent enzymes: new aspects of asymmetric C-C bond formation. , 2002, Chemistry.
[34] Yvonne Genzel,et al. Enhancing the enantioselectivity of an epoxide hydrolase by directed evolution. , 2004, Organic letters.
[35] William R. Strohl,et al. Biotechnology of antibiotics , 1997 .
[36] V. Sabesan,et al. Enzymatic Hydrolysis of a Prochiral 3‐Substituted Glutarate Ester, an Intermediate in the Synthesis of an NK1/NK2 Dual Antagonist , 2001 .
[37] R. N. Brogden,et al. Buspirone: An Updated Review of its Clinical Pharmacology and Therapeutic Applications , 1997 .
[38] Ramesh N. Patel. Biocatalysis: Synthesis of Chiral Intermediates for Pharmaceuticals , 2006 .
[39] I. Blair,et al. Metabolism of the antianxiety drug buspirone in human subjects. , 1989, Drug metabolism and disposition: the biological fate of chemicals.
[40] K. Faber,et al. Microbial epoxide hydrolases for preparative biotransformations. , 2001, Current opinion in biotechnology.
[41] J. Stewart,et al. Enantiodivergent, biocatalytic routes to both taxol side chain antipodes. , 2005, The Journal of organic chemistry.
[42] Huimin Zhao,et al. Recent advances in biocatalysis by directed enzyme evolution. , 2006, Combinatorial chemistry & high throughput screening.
[43] David Weiner,et al. An Enzyme Library Approach to Biocatalysis: Development of Nitrilases for Enantioselective Production of Carboxylic Acid Derivatives , 2002 .
[44] R. Sykes,et al. O-Sulfated .beta.-lactam hydroxamic acids (monosulfactams). Novel monocyclic .beta.-lactam antibiotics of synthetic origin , 1982 .
[45] J. Imbach,et al. Nucleoside Analogues as Chemotherapeutic Agents: A Review , 1992 .
[46] K. Terao,et al. Formation of carboxamides by direct condensation of carboxylic acids and amines in alcohols using a new alcohol- and water-soluble condensing agent: DMT-MM , 2001 .
[47] Ramesh N. Patel,et al. Preparation of a chiral synthon for an HBV inhibitor : enzymatic asymmetric hydrolysis of (1α,2β,3α)-2-(benzyloxymethyl)cyclopent-4-ene-1,3-diol diacetate and enzymatic asymmetric acetylation of (1α,2β,3α)-2-(benzyloxymethyl)cyclopent-4-ene-1,3-diol , 2006 .
[48] G. Chuah,et al. Dynamic kinetic resolution of secondary alcohols combining enzyme-catalyzed transesterification and zeolite-catalyzed racemization. , 2007, Chemistry.
[49] Mahmoud Mahmoudian,et al. Biocatalytic Production of Chiral Pharmaceutical Intermediates , 2000 .
[50] V. Gotor,et al. Candida antarctica lipase catalyzed resolution of ethyl (±)-3-aminobutyrate , 1997 .
[51] R. Azerad,et al. Dynamic resolution and stereoinversion of secondary alcohols by chemo-enzymatic processes. , 2000, Current opinion in biotechnology.
[52] A. Matsuda,et al. Nucleoside natural products and related analogs with potential therapeutic properties as antibacterial and antiviral agents , 2007 .
[53] J. Vekemans,et al. Efficient dynamic kinetic resolution of secondary alcohols with a novel tetrafluorosuccinato ruthenium complex , 2006 .
[54] T. LaPorte,et al. Fermentation and isolation of C10-deacetylase for the production of 10-deacetylbaccatin III from baccatin III. , 1995, Biotechnology and bioengineering.
[55] C. Hansch,et al. Comparative Quantitative Structure−Activity Relationship Studies on Anti-HIV Drugs , 1999 .
[56] D. Drucker,et al. Glucagon-like peptide 1 receptor agonists and dipeptidyl peptidase IV inhibitors: new therapeutic agents for the treatment of type 2 diabetes , 2005 .
[57] Keith E. J. Tyo,et al. Expanding the metabolic engineering toolbox: more options to engineer cells. , 2007, Trends in biotechnology.
[58] M. Mahmoudian. Development of Bioprocesses for the Generation of Anti-Inflammatory, Anti-Viral and Anti-Leukaemic Agents , 2001 .
[59] E. Rubin,et al. Epothilones: mechanism of action and biologic activity. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[60] S. Harusawa,et al. A synthesis of taxusin , 1988 .
[61] R. Parker,et al. Synthesis, biological profile, and quantitative structure-activity relationship of a series of novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. , 1990, Journal of medicinal chemistry.
[62] I. Purvis,et al. Enzymatic production of optically pure (2'R-cis)-2'-deoxy-3'-thiacytidine (3TC, lamivudine): a potent anti-HIV agent. , 1993, Enzyme and microbial technology.
[63] K. Faber,et al. Biocatalytic Deracemization Techniques: Dynamic Resolutions and Stereoinversions , 1997 .
[64] P. Schiff,et al. Promotion of microtubule assembly in vitro by taxol , 1979, Nature.
[65] Ramesh N. Patel,et al. Diastereoselective microbial reduction of (S)-[3-chloro-2-oxo-1-(phenylmethyl)propyl]carbamic acid, 1,1-dimethylethyl ester , 2003 .
[66] G. Whitesides,et al. Membrane-enclosed enzymic catalysis (MEEC): a useful, practical new method for the manipulation of enzymes in organic synthesis , 1987 .
[67] Langer Sz,et al. Alpha-adrenoreceptor subtypes in blood vessels: physiology and pharmacology. , 1984 .
[68] C. Datz,et al. Combination of interferon induction therapy and ribavirin in chronic hepatitis C , 2001, Hepatology.
[69] V. Alphand,et al. Optimizing Fermentation Conditions of Recombinant Escherichia coli Expressing Cyclopentanone Monooxygenase , 2006 .
[70] Georg A. Sprenger,et al. Microbial aldolases as C–C bonding enzymes—unknown treasures and new developments , 2006, Applied Microbiology and Biotechnology.
[71] Manfred T. Reetz,et al. Converting Phenylacetone Monooxygenase into Phenylcyclohexanone Monooxygenase by Rational Design: Towards Practical Baeyer-Villiger Monooxygenases , 2005 .
[72] Marko D. Mihovilovic,et al. Enzyme Mediated Baeyer-Villiger Oxidations , 2006 .
[73] D. Robertson,et al. Potassium channel modulators: scientific applications and therapeutic promise. , 1990, Journal of medicinal chemistry.
[74] Chi-Huey Wong,et al. Unprecedented Asymmetric Aldol Reactions with Three Aldehyde Substrates Catalyzed by 2-Deoxyribose-5-phosphate Aldolase , 1994 .
[75] Yeuk-Chuen Liu,et al. A practical chemoenzymic synthesis of the taxol C-13 side chain N-benzoyl-(2R,3S)-3-phenylisoserine , 1993 .
[76] J. Tao,et al. An efficient synthesis of a key intermediate for the preparation of the rhinovirus protease inhibitor AG7088 via asymmetric dianionic cyanomethylation of N-Boc-l-(+)-glutamic acid dimethyl ester , 2001 .
[77] R. Csuk,et al. Baker's yeast mediated transformations in organic chemistry , 1991 .
[78] L. White. HPLC in clinical microbiology laboratories. , 1981, The Journal of antimicrobial chemotherapy.
[79] M. Ondetti,et al. Inhibition of the renin-angiotensin system. A new approach to the therapy of hypertension. , 1981, Journal of medicinal chemistry.
[80] M. Fraaije,et al. Altering the substrate specificity and enantioselectivity of phenylacetone monooxygenase by structure-inspired enzyme redesign , 2007 .
[81] B Rubin,et al. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. , 1977, Science.
[82] Michael Müller,et al. Regio and enantioselective reduction of t-butyl 6-chloro-3,5-dioxohexanoate with baker’s yeast , 2004 .
[83] Ramesh N. Patel,et al. Enzymatic synthesis of L-6-hydroxynorleucine. , 1999, Bioorganic & medicinal chemistry.
[84] R. Furstoss,et al. Biocatalytic Approaches for the Synthesis of Enantiopure Epoxides , 1999 .
[85] U. Bornscheuer,et al. Cloning, expression, and characterization of a Baeyer–Villiger monooxygenase from Pseudomonas fluorescens DSM 50106 in E. coli , 2007, Applied Microbiology and Biotechnology.
[86] A. Kinney. Metabolic engineering in plants for human health and nutrition. , 2006, Current opinion in biotechnology.
[87] D. Kingston,et al. The chemistry of taxol. , 1991, Pharmacology & therapeutics.
[88] R. Coates,et al. Synthesis and characterization of aza analog inhibitors of squalene and geranylgeranyl diphosphate synthases. , 1992 .
[89] V. Alphand,et al. Microbial transformations 59: first kilogram scale asymmetric microbial Baeyer-Villiger oxidation with optimized productivity using a resin-based in situ SFPR strategy. , 2005, Biotechnology and bioengineering.
[90] Wei Zhang,et al. Highly enantioselective epoxidation catalysts derived from 1,2-diaminocyclohexane , 1991 .
[91] M. Yagasaki,et al. Industrial biotransformations for the production of d-amino acids , 1998 .
[92] M. R. Feng,et al. Mediation of Highly Concentrative Uptake of Pregabalin by L-Type Amino Acid Transport in Chinese Hamster Ovary and Caco-2 Cells , 2005, Journal of Pharmacology and Experimental Therapeutics.
[93] W. Fessner,et al. Biocatalytic synthesis of hydroxylated natural products using aldolases and related enzymes. , 2001, Current opinion in biotechnology.
[94] D. Matthews,et al. Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacements. , 1998, Journal of medicinal chemistry.
[95] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[96] R. Jain,et al. Enzymatic kinetic resolution of piperidine atropisomers: synthesis of a key intermediate of the farnesyl protein transferase inhibitor, SCH66336. , 2000, The Journal of organic chemistry.
[97] C. T. Evans,et al. Potential use of carbocyclic nucleosides for the treatment of AIDS: chemo-enzymatic syntheses of the enantiomers of carbovir , 1992 .
[98] C. Allen,et al. Aromatic dioxygenases: molecular biocatalysis and applications. , 2001, Current opinion in biotechnology.
[99] Y. Kita,et al. A dynamic kinetic resolution of allyl alcohols by the combined use of lipases and [VO(OSiPh3)3]. , 2006, Angewandte Chemie.
[100] J. Bäckvall,et al. Dynamic Kinetic Resolution of β-Azido Alcohols. An Efficient Route to Chiral Aziridines and β-Amino Alcohols , 2001 .
[101] J. Tao,et al. Cloning and optimization of a nitrilase for the synthesis of (3S)-3-cyano-5-methyl hexanoic acid , 2006 .
[102] E. White,et al. Comparison of the effect of Carbovir, AZT, and dideoxynucleoside triphosphates on the activity of human immunodeficiency virus reverse transcriptase and selected human polymerases. , 1989, Biochemical and biophysical research communications.
[103] U. Kragl,et al. N‐Acetylneuraminic Acid From a Rare Chemical from Natural Sources to a Multikilogram Enzymatic Synthesis for Industrial Application , 1995 .
[104] R. Parker,et al. Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. , 2005, Journal of medicinal chemistry.
[105] M. Chartrain,et al. Bioconversion of indene to cis (1S,2R) indandiol and trans (1R,2R) indandiol by Rhodococcus species , 1998 .
[106] Ramesh N. Patel,et al. Stereoselective acetylation of [1-(hydroxy)-4-(3-phenyl)butyl]phosphonic acid, diethyl ester , 1997 .
[107] Ramesh N. Patel,et al. Synthesis of l-β-hydroxyvaline from α-keto-β-hydroxyisovalerate using leucine dehydrogenase from Bacillus species , 1990 .
[108] O. Ward,et al. Optimisation of reaction conditions for production ofS-(−)-2-hydroxypropiophenone byAcinetobacter calcoaceticus , 1994, Journal of Industrial Microbiology.
[109] G. Schulz,et al. Chemie der pleuromutiline—IV: Synthese des 14-O-acetyl-8α-hydroxy-mutilins , 1983 .
[110] Chi-Huey Wong,et al. Recent advances in aldolase-catalyzed asymmetric synthesis , 2007 .
[111] Ramesh N. Patel,et al. Enzymatic synthesis of chiral intermediates for Omapatrilat, an antihypertensive drug. , 2001, Biomolecular engineering.
[112] J. Stewart,et al. Application of newly available bio-reducing agents to the synthesis of chiral hydroxy-β-lactams: model for aldose reductase selectivity , 2005 .
[113] G. Wong,et al. Pilot-Scale Lipase-Catalyzed Regioselective Acylation of Ribavirin in Anhydrous Media in the Synthesis of a Novel Prodrug Intermediate , 2003 .
[114] E. Jacobsen,et al. A Practical, Highly Enantioselective Synthesis of the Taxol Side Chain via Asymmetric Catalysis. , 1992 .
[115] Michael Müller,et al. Asymmetric benzoin reaction catalyzed by benzoylformate decarboxylase , 1999 .
[116] C. Wandrey,et al. Highly Regio- and Enantioselective Reduction of 3,5-Dioxocarboxylates. , 2000, Angewandte Chemie.
[117] B Hauer,et al. Continuous production of (R)-phenylacetylcarbinol in an enzyme-membrane reactor using a potent mutant of pyruvate decarboxylase from Zymomonas mobilis. , 2001, Biotechnology and bioengineering.
[118] Ramesh N. Patel,et al. Biocatalytic ammonolysis of (5S)-4,5-dihydro-1H-pyrrole-1,5-dicarboxylic acid, 1-(1,1-dimethylethyl)-5-ethyl ester: preparation of an intermediate to the dipeptidyl peptidase IV inhibitor Saxagliptin. , 2006, Bioorganic & medicinal chemistry letters.
[119] J. Kessler,et al. Activities of (-)-carbovir and 3'-azido-3'-deoxythymidine against human immunodeficiency virus in vitro , 1990, Antimicrobial Agents and Chemotherapy.
[120] R. Hanson,et al. Regioselective enzymatic aminoacylation of lobucavir to give an intermediate for lobucavir prodrug. , 2000, Bioorganic & medicinal chemistry.
[121] G. Allan,et al. Microbial deracemization of 1-aryl and 1-heteroaryl secondary alcohols. , 2001, The Journal of organic chemistry.
[122] Ramesh N. Patel,et al. Biocatalytic preparation of a chiral synthon for a vasopeptidase inhibitor: enzymatic conversion of N2-[N-Phenylmethoxy)carbonyl] L-homocysteinyl]- L-lysine (1- > 1′)-disulfide to [4S-(4I,7I,10aJ)] 1-octahydro-5-oxo-4-[phenylmethoxy)carbonyl]amino]-7H-pyrido-[2,1-b] [1,3]thiazepine-7-carboxylic acid , 2000 .
[123] Martha Lovato Tse,et al. Precursor-directed biosynthesis of epothilone in Escherichia coli. , 2004, Journal of the American Chemical Society.
[124] Ramesh N. Patel. Biocatalysis in the pharmaceutical and biotechnology industries , 2006 .
[125] Daeho Kim,et al. (S)-selective dynamic kinetic resolution of secondary alcohols by the combination of subtilisin and an aminocyclopentadienylruthenium complex as the catalysts. , 2003, Journal of the American Chemical Society.
[126] David W. Smith,et al. 2,3-Benzodiazepin-1,4-diones as peptidomimetic inhibitors of γ-secretase , 2004 .
[127] M. Seiden,et al. BMS-247550 Bristol-Myers Squibb/GBF. , 2003, Current opinion in investigational drugs.
[128] F. Arnold,et al. Stereoselective hydroxylation of an achiral cyclopentanecarboxylic acid derivative using engineered P450s BM-3. , 2005, Chemical communications.
[129] R. Hanson,et al. Site-specific enzymatic hydrolysis of taxanes at C-10 and C-13. , 1994, The Journal of biological chemistry.
[130] W. Fessner. Enzyme‐catalyzed Aldol Additions , 2008 .
[131] James G. Tarrant,et al. The discovery of BMS-275183: an orally efficacious novel taxane. , 2003, Bioorganic & medicinal chemistry.
[132] Hiroaki Yamamoto,et al. Practical application of recombinant whole-cell biocatalysts for the manufacturing of pharmaceutical intermediates such as chiral alcohols , 2002 .
[133] C. Wilcox,et al. Serotonin 5-HT1a Receptor Agonists as Antidepressants , 1998 .
[134] D. Hutchinson. New approaches to the synthesis of antiviral nucleosides. , 1990, Trends in biotechnology.
[135] Daniel Mink,et al. Directed evolution of an industrial biocatalyst: 2-deoxy-D-ribose 5-phosphate aldolase. , 2006, Biotechnology journal.
[136] L. L. Nielsen. Incretin mimetics and DPP-IV inhibitors for the treatment of type 2 diabetes. , 2005, Drug discovery today.
[137] C. Hewitt,et al. Application of multi-parameter flow cytometry using fluorescent probes to study substrate toxicity in the indene bioconversion. , 2002, Biotechnology and bioengineering.
[138] M. Kreiner,et al. Microbial hydroxylation of 2-cycloalkylbenzoxazoles. Part III. Determination of product enantiomeric excess and cleavage of benzoxazoles , 1996 .
[139] J. W. Frost,et al. Prospects for Biocatalytic Synthesis of Aromatics in the 21st Century , 1994 .
[140] U. Schwaneberg,et al. Directed evolution of oxygenases: screening systems, success stories and challenges. , 2007, Combinatorial chemistry & high throughput screening.
[141] C. Mcnamee,et al. Stereoselective epoxidation of 2,2-dimethyl-2H-1-benzopyran-6-carbonitrile. , 1994, Bioorganic & medicinal chemistry.
[142] Jaiwook Park,et al. Dynamic kinetic resolution of primary amines with a recyclable Pd nanocatalyst for racemization. , 2007, Organic letters.
[143] T. Kitahara,et al. Preparation of chiral cyclohexanol derivative with high optical purity by yeast reduction , 1985 .
[144] M. Mihovilovic,et al. Monooxygenase‐Mediated Baeyer−Villiger Oxidations , 2002 .
[145] Ramesh N. Patel,et al. Enzymic hydrolysis of 7‐xylosyltaxanes by xylosidase from Moraxella sp. , 1997 .
[146] A. Carnell. Stereoinversions using microbial redox-reactions. , 1999, Advances in biochemical engineering/biotechnology.
[147] V. Gotor,et al. Biocatalytic selective modifications of conventional nucleosides, carbocyclic nucleosides, and C-nucleosides. , 2000, Chemical reviews.
[148] C. Fairchild,et al. Preclinical pharmacology of BMS-275183, an orally active taxane. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[149] Christopher Williamson,et al. Synthesis from (–)-aristeromycin and X-ray structure of (–)-carbovir , 1991 .
[150] C. Wong,et al. Chemo-enzymatic total synthesis of 3-epiaustraline, australine, and 7-epialexine. , 2000, The Journal of organic chemistry.
[151] B. Gallwitz. Glucagon- Like Peptide-1-Based Therapies for the Treatment of Type 2 Diabetes Mellitus , 2005, Treatments in endocrinology.
[152] M. Deninno. The Synthesis and Glycosidation of N-Acetylneuraminic Acid , 1991 .
[153] M. Mahmoudian,et al. Enzymic acylation of 506U78 (2‐amino‐9‐β‐D‐arabinofuranosyl‐6‐methoxy‐9H‐purine), a powerful new anti‐leukaemic agent , 1999, Biotechnology and applied biochemistry.
[154] Ramesh N. Patel,et al. Enantioselective microbial reduction of substituted acetophenones , 2004 .
[155] W. Kroutil,et al. Enzymatic Racemisation and its Application to Synthetic Biotransformations , 2003 .
[156] Ramesh N. Patel,et al. Preparation of an Amino Acid Intermediate for the Dipeptidyl Peptidase IV Inhibitor, Saxagliptin, using a Modified Phenylalanine Dehydrogenase , 2007 .
[157] Richard L. Pederson,et al. Enzyme-catalyzed aldol condensation for asymmetric synthesis of azasugars : synthesis, evaluation, and modeling of glycosidase inhibitors , 1991 .
[158] G. Borisy,et al. Characterization of microtubule assembly in porcine brain extracts by viscometry. , 1973, Biochemistry.
[159] Ramesh N. Patel,et al. Asymmetric acyloin condensation catalyzed by phenylpyruvate decarboxylase , 1999 .
[160] Klaus Buchholz,et al. Biocatalysts and Enzyme Technology , 2005 .
[161] Georg A. Sprenger,et al. Synthetic potential of thiamin diphosphate-dependent enzymes , 1999 .
[162] Michael L. Shuler,et al. Taxol®: science and applications. , 1995 .
[163] Y. Hashimoto,et al. Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity. , 1988, Journal of medicinal chemistry.
[164] Harris,et al. Synthesis of allysine ethylene acetal using phenylalanine dehydrogenase from Thermoactinomyces intermedius. , 2000, Enzyme and microbial technology.
[165] S. Sauleda,et al. Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus–infected patients with congenital coagulation disorders , 2001, Hepatology.
[166] Frances H Arnold,et al. Synthetic gene circuits: design with directed evolution. , 2007, Annual review of biophysics and biomolecular structure.
[167] A. Baldessari,et al. One-pot biocatalyzed preparation of substituted amides as intermediates of pharmaceuticals , 2001 .
[168] M. Burk,et al. Creation of a productive, highly enantioselective nitrilase through gene site saturation mutagenesis (GSSM). , 2003, Journal of the American Chemical Society.
[169] V. Gotor. Lipases and (R)-oxynitrilases: useful tools in organic synthesis. , 2002, Journal of biotechnology.
[170] M. Hirama,et al. A chiral total synthesis of compactin , 1982 .
[171] D K Robinson,et al. Metabolic engineering and directed evolution for the production of pharmaceuticals. , 2000, Current opinion in biotechnology.
[172] V. Alphand,et al. Microbiological transformations. 22. Microbiologically mediated Baeyer-Villiger reactions: a unique route to several bicyclic .gamma.-lactones in high enantiomeric purity , 1992 .
[173] N. Turner,et al. A versatile chemo-enzymatic route to enantiomerically pure β-branched α-amino acids , 2004 .
[174] O. Ward,et al. Reductive biotransformations of organic compounds by cells or enzymes of yeast. , 1990, Enzyme and microbial technology.
[175] R. Storer,et al. The Resolution and Absolute Stereochemistry of the Enantiomers of cis-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine (BCH189): Equipotent Anti-HIV Agents , 1993 .
[176] S. Danishefsky,et al. Novel stereospecific silyl group transfer reactions: practical routes to the prostaglandins , 1989 .
[177] N. Vanthuyne,et al. Dynamic kinetic resolution of amines involving biocatalysis and in situ free radical mediated racemization. , 2007, Organic letters.
[178] Manfred T Reetz,et al. Designing new Baeyer-Villiger monooxygenases using restricted CASTing. , 2006, The Journal of organic chemistry.
[179] B. Martín‐Matute,et al. Dynamic kinetic resolution catalyzed by enzymes and metals. , 2007, Current opinion in chemical biology.
[180] J. Cameron,et al. The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro , 1992, Antimicrobial Agents and Chemotherapy.
[181] Eric Mathur,et al. Exploring Nitrilase Sequence Space for Enantioselective Catalysis , 2004, Applied and Environmental Microbiology.
[182] Chi‐Huey Wong,et al. Enzymes in carbohydrate synthesis: N-acetylneuraminic acid aldolase catalyzed reactions and preparation of N-acetyl-2-deoxy-D-neuraminic acid derivatives , 1988 .
[183] D. Robertson,et al. Chapter 10. Potassium Channel Openers: New Biological Probes , 1989 .
[184] V. Wendisch,et al. Metabolic engineering of Escherichia coli and Corynebacterium glutamicum for biotechnological production of organic acids and amino acids. , 2006, Current opinion in microbiology.
[185] Hydroxylation of Mutilin by Streptomyces griseus and Cunninghamella echinulata , 2002 .
[186] J. B. Jones,et al. Enzymes in organic synthesis. 34. Preparations of enantiomerically pure exo- and endo-bridged bicyclic [2.2.1] and [2.2.2] chiral lactones via stereospecific horse liver alcohol dehydrogenase catalyzed oxidations of meso diols , 1985 .
[187] V. Alphand,et al. Asymmetric Baeyer–Villiger Biooxidation of α‐Substituted Cyanocyclohexanones: Influence of the Substituent Length on Regio‐ and Enantioselectivity , 2007 .
[188] Karlheinz Drauz,et al. Enzyme Catalysis in Organic Synthesis , 1995 .
[189] Ramesh N. Patel,et al. Chemical and Enzymatic Resolution of (R,S)-N-(tert-Butoxycarbonyl)-3-hydroxymethylpiperidine , 2001 .
[190] S. Danishefsky,et al. The Total Synthesis of Allosamidin. Expansions of the Methodology of Azaglycosylation Pursuant to the Total Synthesis of Allosamidin. A Surprising Enantiotopic Sense for a Lipase-Induced Deacetylation , 1996 .
[191] B. Buckland,et al. Directed evolution of toluene dioxygenase from Pseudomonas putida for improved selectivity toward cis-indandiol during indene bioconversion. , 2000, Metabolic engineering.
[192] W. Suen,et al. Improved activity and thermostability of Candida antarctica lipase B by DNA family shuffling. , 2004, Protein engineering, design & selection : PEDS.
[193] J. Binet,et al. Synthesis and antihypertensive activity of a series of 4-amino-6,7-dimethoxyquinazoline derivatives. , 1986, Journal of medicinal chemistry.
[194] N. Trippodo,et al. Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase. , 1997, Journal of medicinal chemistry.
[195] Uwe T Bornscheuer,et al. Methods to increase enantioselectivity of lipases and esterases. , 2002, Current opinion in biotechnology.
[196] M. Kula,et al. Dehydrogenases for the synthesis of chiral compounds. , 1989, European journal of biochemistry.
[197] T. Pabst,et al. Large-Scale Synthesis of (R)-2-Amino-1-(2-furyl)ethanol via a Chemoenzymatic Approach , 2006 .
[198] T. Hamilton,et al. Synthesis and antihypertensive activity of 6,7-disubstituted trans-4-amino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-3-ols. , 1983, Journal of medicinal chemistry.
[199] J. Clardy,et al. Antileukemic alkaloids from Taxus wallichiana Zucc , 1981 .
[200] Albrecht Berkessel,et al. Lipase/aluminum-catalyzed dynamic kinetic resolution of secondary alcohols. , 2006, Angewandte Chemie.
[201] Nicholas J Turner,et al. Enzyme catalysed deracemisation and dynamic kinetic resolution reactions. , 2004, Current opinion in chemical biology.
[202] C. Hamilton,et al. Recent developments in preparative enzymatic syntheses of carbohydrates. , 2006, Natural product reports.
[203] M. Reetz,et al. Lipase-Catalyzed Dynamic Kinetic Resolution of Chiral Amines: Use of Palladium as the Racemization Catalyst , 1996, CHIMIA.
[204] D. Ghisotti,et al. Immobilized Biocatalysts for the Production of Nucleosides and Nucleoside Analogues by Enzymatic Transglycosylation Reactions , 2004 .
[205] M. Delcourt,et al. Directed Evolution of Biocatalysts , 2006 .
[206] B. Martín‐Matute,et al. (S)-selective kinetic resolution and chemoenzymatic dynamic kinetic resolution of secondary alcohols. , 2006, Chemistry.
[207] F. Effenberger,et al. Enzym‐katalysierte Synthese von 1‐Desoxymannojirimycin, 1‐Desoxynojirimycin und 1,4‐Didesoxy‐1,4‐imino‐D‐arabinitol , 1988 .
[208] J. Snyder,et al. Biochemistry and physiology of microtubules. , 1976, Annual review of biochemistry.
[209] L. Itri,et al. Retinoids and Cancer , 1984 .
[210] Ramesh N. Patel,et al. Stereoselective reduction of β-keto esters by Geotrichum candidum , 1992 .
[211] V. Urlacher,et al. Microbial P450 enzymes in biotechnology , 2004, Applied Microbiology and Biotechnology.
[212] Ramesh N. Patel,et al. Stereospecific enzymatic hydrolysis of racemic epoxide: a process for making chiral epoxide , 1999 .
[213] Marco W. Fraaije,et al. Baeyer-Villiger monooxygenases, an emerging family of flavin-dependent biocatalysts , 2003 .
[214] Daeho Kim,et al. Dynamic kinetic resolution of secondary alcohols by enzyme–metal combinations in ionic liquid , 2004 .
[215] David A. Stock,et al. BMS-232632, a Highly Potent Human Immunodeficiency Virus Protease Inhibitor That Can Be Used in Combination with Other Available Antiretroviral Agents , 2000, Antimicrobial Agents and Chemotherapy.
[216] E. Baloglu,et al. A new semisynthesis of paclitaxel from baccatin III. , 1999, Journal of Natural Products.
[217] A. Iribarren,et al. Microbial Synthesis of Antiviral Nucleosides Using Escherichia coli BL21 as Biocatalyst , 2002 .
[218] Chi‐Huey Wong,et al. Enzyme-catalyzed organic synthesis: practical routes to aza sugars and their analogs for use as glycoprocessing inhibitors , 1993 .
[219] J. Smith. Synthetically Useful Reactions of Epoxides , 1984 .
[220] J. Harting,et al. 3-Methyl-2H-1-benzopyran potassium channel activators. , 1991, Journal of medicinal chemistry.
[221] D. M. Ryan,et al. Rational design of potent sialidase-based inhibitors of influenza virus replication , 1993, Nature.
[222] Jie Chen,et al. N-[2-[2-(4-Phenylbutyl)benzofuran-4-yl]cyclopropylmethyl]acetamide: an orally bioavailable melatonin receptor agonist. , 2004, Bioorganic & medicinal chemistry letters.
[223] Chiehying Y Chang,et al. Discovery of a (1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitumor activity. , 2005, Journal of medicinal chemistry.
[224] Jaiwook Park,et al. Dynamic Kinetic Resolutions and Asymmetric Transformations by Enzyme-Metal Combo Catalysis , 2005 .
[225] P. Seubert,et al. Potential treatment opportunities for Alzheimer’s disease through inhibition of secretases and Aβ immunization , 2001, Journal of Molecular Neuroscience.
[226] J. Mestan,et al. New aza-dipeptide analogues as potent and orally absorbed HIV-1 protease inhibitors: candidates for clinical development. , 1998, Journal of medicinal chemistry.
[227] Ramesh N. Patel,et al. Enantioselective microbial reduction of 3,5-dioxo-6-(benzyloxy) hexanoic acid, ethyl ester , 1993 .
[228] M Jason MacDonald,et al. A modern view of phenylalanine ammonia lyase. , 2007, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[229] R. Schwartz,et al. Stereoselective epoxidation of octadiene catalyzed by an enzyme system of Pseudomonas oleovorans. , 1974, Journal of the American Chemical Society.
[230] A. Linden. Epoxidation of α-olefins by heptane-grown Pseudomonas cells , 1963 .
[231] F. Arnold,et al. Protein engineering of oxygenases for biocatalysis. , 2002, Current opinion in chemical biology.
[232] Chi‐Huey Wong,et al. Enzymes in Organic Synthesis: Aldolase‐Mediated Synthesis of Iminocyclitols and Novel Heterocycles , 2007 .
[233] Ramesh N. Patel,et al. Synthesis and activity of a C-8 keto pleuromutilin derivative. , 2003, Bioorganic & Medicinal Chemistry Letters.
[234] R. Kazlauskas. Enhancing catalytic promiscuity for biocatalysis. , 2005, Current opinion in chemical biology.
[235] M. Chartrain,et al. Biocatalysis for pharmaceuticals--status and prospects for a key technology. , 2000, Metabolic engineering.
[236] S. Shimizu,et al. Microbial and Enzymatic Processes for the Production of Biologically and Chemically Useful Compounds [New Synthetic Methods (69)] , 1988 .
[237] B. M. Pinto,et al. The anomeric effect in 2-arylseleno-1,3-dithianes , 1985 .
[238] J. S. Wells,et al. Monobactams—monocyclic β -lactam antibiotics produced by bacteria , 1981 .
[239] K. Altmann. The merger of natural product synthesis and medicinal chemistry: on the chemistry and chemical biology of epothilones. , 2004, Organic & biomolecular chemistry.
[240] J. Stewart. Dehydrogenases and transaminases in asymmetric synthesis. , 2001, Current opinion in chemical biology.
[241] A. McPhail,et al. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. , 1971, Journal of the American Chemical Society.
[242] Ramesh N. Patel,et al. Enzymatic preparation of (3R)-cis-3-acetyloxy-4-(1,1-dimethylethyl)-2-azetidinone: a side-chain synthon for an orally active taxane , 2003 .
[243] Kurt Faber,et al. Biotransformations in Organic Chemistry , 1992 .
[244] J. Woodley,et al. Towards large-scale synthetic applications of Baeyer-Villiger monooxygenases. , 2003, Trends in biotechnology.
[245] Ramesh N. Patel,et al. Purification and Cloning of a Ketoreductase used for the Preparation of Chiral Alcohols , 2005 .
[246] M. Dawson,et al. A practical enzymatic procedure for the resolution of N-substituted 2-azabicyclo[2.2.1]hept-5-en-3-one , 1999 .
[247] Ramesh N. Patel,et al. Enantioselective microbial reduction of 6-oxo-8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione: Cloning and expression of reductases , 2006 .
[248] Enantioselective microbial reduction of 6-oxo-8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione , 2005 .